The global Metabolic Disorder Therapeutics Market size was USD 130.81 billion in 2022, and is expected to reach a value of USD 240.49 billion in 2032, and register a revenue CAGR of 7% during the...
With the development of next-generation sequencing (NGS) technologies and new sequencers, the exponential growth of biological information generated by the scientific community has brought benefi...
CD BioSciences, a US-based CRO serving the global life science research community, has announced a series of new solutions for metabolic homeostasis, including Regulator Characterization, Mechanism...
Asia-Pacific metabolic disorder therapeutics marketis estimated to grow at a CAGR of 8.2% during the forecast period. Obesity and Diabetes is a major health concern in the countries including C...
